Literature DB >> 11559471

Autism spectrum disorders: update of evaluation and treatment.

A G Mikhail1, B H King.   

Abstract

Autistic spectrum disorders are a group of neurodevelopmental conditions that are increasingly capturing the attention of clinicians and investigators. New insights from genetics and neuropathophysiology of autism will increasingly inform treatment. Presently, individualized treatment approaches typically include a mix of behavioral and, occasionally, pharmacotherapeutic strategies. Concerning the latter, exquisite sensitivity to medication is not uncommon in some children with autism.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11559471     DOI： 10.1007/s11920-996-0027-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  33 in total

1.  Autism and the cerebellum: evidence from tuberous sclerosis.

Authors:  A M Weber; J C Egelhoff; J M McKellop; D N Franz
Journal:  J Autism Dev Disord       Date:  2000-12

2.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

3.  The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions.

Authors:  H D Critchley; E M Daly; E T Bullmore; S C Williams; T Van Amelsvoort; D M Robertson; A Rowe; M Phillips; G McAlonan; P Howlin; D G Murphy
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

4.  Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities.

Authors:  B H King; D M Wright; M Snape; C T Dourish
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-06       Impact factor: 8.829

5.  Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society.

Authors:  P A Filipek; P J Accardo; S Ashwal; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S W Teplin; R F Tuchman; F R Volkmar
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

Review 6.  Review of neuroimaging studies of child and adolescent psychiatric disorders from the past 10 years.

Authors:  R L Hendren; I De Backer; G J Pandina
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-07       Impact factor: 8.829

7.  Corpus callosum size in autism.

Authors:  A Y Hardan; N J Minshew; M S Keshavan
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

8.  Prolongation of brainstem auditory-evoked responses in autistic probands and their unaffected relatives.

Authors:  M Maziade; C Mérette; M Cayer; M A Roy; P Szatmari; R Côté; J Thivierge
Journal:  Arch Gen Psychiatry       Date:  2000-11

Review 9.  MRI neuroimaging of childhood psychiatric disorders: a selective review.

Authors:  S Eliez; A L Reiss
Journal:  J Child Psychol Psychiatry       Date:  2000-09       Impact factor: 8.982

10.  A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

Authors:  C J McDougle; J P Holmes; D C Carlson; G H Pelton; D J Cohen; L H Price
Journal:  Arch Gen Psychiatry       Date:  1998-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.